Search Results
Apr 23, 2026, 09:00 ET Decera Clinical Appoints Industry Veteran Guy Slatcher, Ph.D., as President of Medical Communications
multimedia:https://www.prnewswire.com/news-releases/decera-clinical-appoints-industry-veteran-guy-slatcher-phd-as-president-of-medical-communications-302750967.htmlSOURCE
More news about: Decera Clinical
Apr 23, 2026, 08:30 ET CENTURY LITHIUM ADVANCES DEMONSTRATION PLANT RELOCATION TO TONOPAH AND PROVIDES REAGENT COST STRUCTURE UPDATE
centurylithium.com.ON BEHALF OF CENTURY LITHIUM CORP.WILLIAM WILLOUGHBY, PhD., PE President & Chief Executive OfficerNEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER ACCEPTS RESPONSIBILITY
More news about: Century Lithium Corp.
Apr 23, 2026, 08:00 ET Avesta Ketamine and Wellness Expands to Norfolk, Virginia
improve access to mental health treatments for those struggling with suicidality and other mental health struggles," said Dr. Ladan Eshkevari, CRNA, PhD, FAAN, founder and co-CEO of Avesta. "Norfolk and the greater Hampton Roads region have been on our radar for some time, as we've had patients from southern
More news about: Avesta Ketamine and Wellness
Apr 23, 2026, 08:00 ET Repertoire Immune Medicines Announces First Participant Dosed in Phase 1/2 Trial of RPTR-1-201, a T Cell-Targeted Immune Medicine for Advanced Solid Tumors
generated an optimized TCR bispecific immune medicine that harnesses the immune system against difficult-to-treat solid tumors," said Anthony J. Coyle, PhD, President, Research and Development at Repertoire. "The initiation of this trial marks an important milestone, as RPTR-1-201 is the first validation
More news about: Repertoire Immune Medicines
Apr 23, 2026, 04:00 ET Faculty Launches Frontier Plug-in Marketplace, Accelerating How Organisations Build and Scale Decision Intelligence
we work for the world's leading AI labs, such as OpenAI, Anthropic and Meta, to ensure their latest models are safe, human-led and explainable. Our PhD-heavy team of deep AI experts has delivered hundreds of real-world AI products to improve critical public services and drive sustained economic returns
More news about: Faculty
Apr 22, 2026, 12:22 ET Pendulum, the Breakthrough Gut Health Brand, Launches Nationwide at Sprouts Farmers Market
gut."Many people assume that a slowdown in metabolism and energy is just an inevitable part of aging—but it doesn't have to be," said Colleen Cutcliffe, PhD, Co-founder and CEO of Pendulum. "More than ever, people are looking for ways to feel vibrant, energized, and in control of their health as they age.
More news about: Pendulum Therapeutics
Apr 22, 2026, 11:07 ET Brain Support Cells Form Previously Unknown Network
study are Maria Clara Selles, PhD; Michael Cammer, MFA, MAT; Holly Gildea, PhD; Joseph Sall; and Katelyn Chiurri. Other study co-investigators are Chase Redd, Philip Cheung, MD, and Damian Wheeler, PhD, at Translucence Biosystems in Irvine, California; and Aiman Saab, PhD, at the University of Zurich in
More news about: NYU Grossman School of Medicine and NYU Langone Health
Apr 22, 2026, 11:01 ET Pulmonary Fibrosis Foundation Expands Leadership To Drive Scientific and Partnership Strategy
Jessica Shore, PhD, RN, named Chief Scientific Officer; Jennifer Mefford named Chief Partnerships OfficerCHICAGO, April 22, 2026 /PRNewswire/ -- The
More news about: The Pulmonary Fibrosis Foundation
Apr 22, 2026, 11:00 ET Momcozy Partners with Postpartum Support International for Mother's Day Campaign
Support International, we believe every family deserves a strong, supported start during one of life's most profound transitions," said Wendy N. Davis, PhD, PMH-C, President and CEO of PSI. "Perinatal mental health is at the heart of family wellbeing, and each stage of the journey can bring its own challenges.
More news about: Momcozy
Apr 22, 2026, 10:59 ET Nelson Oyesiku, M.D., Named Chief of Neurosciences at Piedmont
ATLANTA, April 22, 2026 /PRNewswire/ -- Piedmont has named Nelson Oyesiku, M.D., PhD, FACS, an internationally-recognized Neurosciences leader, Chief of Neurosciences for the healthcare system. Dr. Oyesiku was most recently professor
More news about: Piedmont Healthcare
Apr 22, 2026, 10:00 ET RIVANNA expands multi-site clinical study for Accuro XV musculoskeletal imaging system
actively enrolling patients, development of AI for fracture detection is anticipated to compress the 510(k)-submission timeline," said Delphine Le Roux, PhD, PMP, Senior Director, Market Access and Strategic Partnerships at RIVANNA. "Expanding our clinical program from two to eight sites in four months, with
More news about: RIVANNA
Apr 22, 2026, 09:30 ET Made Scientific and Regenicin Announce Manufacturing Relationship to Advance NovaDerm Toward FDA Product Approval
expertise in autologous manufacturing gives us confidence as we move toward our IND submission and first-in-human clinical trial," said Dr. K. E. Castro, PhD, Director of Clinical Studies at Regenicin.With industry-leading development and manufacturing capabilities and continued investment in state-of-the
More news about: Made Scientific, Inc.
Apr 22, 2026, 08:30 ET Neuroscience Drug Development: How Novel Applications of AI Could Meaningfully Disrupt Traditional Development Strategies, Upcoming Webinar Hosted by Xtalks
Clario, Todd Rudo (Moderator), MD, EVP, Chief Medical Officer; Mark Opler, PhD, Chief Research Officer, eCOA Neuroscience; Alex Boudreau, Director, AI; and Joël Schaerer, PhD, Senior Director, Imaging AI, for the live webinar on Wednesday, May 13, 2026, at 11am EDT (5pm CEST/EU-Central).For
More news about: Xtalks
Apr 22, 2026, 08:00 ET Thryv Therapeutics Commences Patient Dosing in Wave II Clinical Study for Long QT Syndrome and Receives FDA Fast Track Designation for THRV-1268
change in QTcF over six hours, together with evaluations of cardiac rhythm stability, safety, and tolerability.Professor Vasanth Vedantham, MD, PhD, at UCSF Health in San Francisco, California, initiated the first of fourteen patients planned in Part A of the Wave II study."The
More news about: Thryv Therapeutics Inc.
Apr 22, 2026, 08:00 ET RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical Studies - New Data Presented at AACR 2026
The positive NB data, from studies undertaken by Penn State University's Jeremy Hengst, PhD, and Apogee Biotechnology funded by the Beat Childhood Cancer Foundation and Four Diamonds, indicate that opaganib may enhance the therapeutic efficacy
More news about: RedHill Biopharma Ltd.
Apr 22, 2026, 07:57 ET New Book Introduces "Business Fiction" to Demonstrate How Companies Could Soon Run Themselves, and Why Leaders Need to Prepare Now
Barnes & NobleAbout the authorNick Pogrebnyakov holds a PhD in Information Sciences and Technology from Penn State and was an Associate Professor of International Business at Copenhagen Business School, Denmark
More news about: Archway Publishing
Apr 22, 2026, 07:30 ET BTQ Technologies Appoints Dr. Gopikrishnan Muraleedharan as Head of Quantum Algorithm and Applications Research, Advances Sydney Operations and Global Quantum Initiatives
Dr. Muraleedharan brings more than a decade of research experience in quantum algorithms, quantum information, and quantum simulations. He holds a PhD in Physics from the University of New Mexico and completed postdoctoral research at Los Alamos National Laboratory and Macquarie University. Over the
More news about: BTQ Technologies Corp.
Apr 22, 2026, 05:27 ET American Parkinson Disease Association Welcomes Three Distinguished Leaders to National Board of Directors
Association (APDA) is proud to announce the appointment of three accomplished leaders to its National Board of Directors: Howard Lenn, Madeleine Shea, PhD, and Sara Whittingham, MD. Each brings unique expertise and a powerful perspective that will help advance APDA's mission to provide the support, education,
More news about: American Parkinson Disease Association, Inc.
Apr 21, 2026, 16:15 ET Vapotherm® Announces FDA 510(k) Clearance for the All Patient Circuit™, Enabling High Velocity Therapy for Neonatal to Adult Patients
outcomes and the care experience across Emergency, ICU, and other hospital settings.Medical Affairs Contact:Jessica Whittle, MD PhDChief Medical Officer | VP Clinical Research | Vapotherm, Inc.100 Domain Drive, Exeter, NH 03833Email:
More news about: Vapotherm, Inc.
Apr 21, 2026, 16:00 ET ISCT Announces Inaugural CGT Clinical Applications Program for Clinical Fellows
inaugural course will be co-chaired by Jaap Jan Boelens, MD, PhD, ISCT Regional Vice President, North America, and Chief of Transplantation and Cellular Therapies at Memorial Sloan Kettering Cancer Center, and Alice Bertaina, MD, PhD, Elected Member MD of the ISCT Board of Directors, and Section
More news about: International Society for Cell & Gene Therapy
Apr 21, 2026, 13:25 ET Mphasis acquires Theory and Practice Business Intelligence Inc., strengthening its 'Decisioning Intelligence' capabilities
is an alumna of Simon Fraser University, where she did her MSc in Experimental Particle Physics, working on ATLAS Detector at CERN and completed her PhD in Economics. Additionally, she spent significant time at the Department of Economics at Stanford University, where she studied under the renowned economist,
More news about: Mphasis
Apr 21, 2026, 11:31 ET Schlumberger Foundation Celebrates Its 1,000th Faculty for the Future Grant
program awarded 163 grants to outstanding women from low‑ and middle-income countries pursuing PhD and postdoctoral research in science, engineering, technology, and mathematics (STEM)KAMPALA, Uganda,
More news about: Schlumberger Foundation
Apr 21, 2026, 11:28 ET Schlumberger Foundation Celebrates Its 1,000th Faculty for the Future Grant
program awarded 163 grants to outstanding women from low‑ and middle-income countries pursuing PhD and postdoctoral research in science, engineering, technology, and mathematics (STEM)KAMPALA, Uganda,
More news about: Schlumberger Foundation
Apr 21, 2026, 11:24 ET MyOme Strengthens Board with Appointment of Two Healthcare Leaders
evidence and regulatory rigor — positions the company to drive significant impact across the healthcare system."- Dr. ThadhaniMatt Rabinowitz, PhD, Co-Founder and Executive Chairman of MyOme, emphasized the importance of the newly appointed board members. "Sam has scaled influential health-data
More news about: MyOme, Inc
Apr 21, 2026, 09:36 ET L-Nutra CEO Dr. Joseph Antoun Named LA Times 'Life Sciences Visionary' for Pioneering Longevity as a Medical Discipline
2026 /PRNewswire/ -- L-Nutra Inc., a leader in science-driven longevity nutrition, today announced that its Chairman and CEO, Joseph Antoun, MD, PhD, has been named a 2026 Life Sciences Visionary by LA Times Studios, recognizing leaders driving innovation across biotechnology and healthcare.
More news about: L-Nutra Inc.